Introduction: Activation of the baroreflex system through the selective vagal nerve
pressure (BP) without major side effects in a rat model. As continuous stimulation is energy consuming and sVNS could be implemented in an antihypertensive stimulator, it was the aim of this study to investigate the efficacy of pulsatile, cardiac-cycle-synchronized sVNS (cssVNS) on the reduction of BP. parameter settings within a window of 15-30 ms after the R-peak in the ECG. The stimulation paradigm included every heartbeat, every second heart beat, and every third heart beat. BP and heart rate were initially recorded over 10 min. Results: Using cssVNS, BP could be significantly reduced over 30 min and maintained at this level. While the highest BP reduction was seen during cssVNS at every heartbeat with minimal bradycardia, less-yet significant-BP reduction was seen during cssVNS at every second or third heartbeat without causing detectable bradycardia.
Conclusion: cssVNS can chronically reduce BP
in rats avoiding measurable bradycardic side effects. This energy-efficient technique might
INTRODUCTION
Arterial hypertension is a common disease affecting millions of patients worldwide.
Despite the development of new efficient medicine, up to 50% of hypertensive patients do not achieve a systolic target blood pressure (BP) below 140 mmHg even under treatment with three antihypertensive drugs [1] .
Non-adherence to medical therapy can be one cause, but it is believed that 5-13% of all those patients are truly therapy resistant [2] .
Non-medical, device-mediated therapies are being investigated to address this problem [3, 4] . Renal denervation was successful in reducing BP in the Symplicity I (NCT00664638) and II (NCT00888433) studies, but failed to beat the control-group in Symplicity III (NCT01418261) [5] . While its complication rate was high in the first Rheos-trial (NCT00442286), carotid sinus stimulation still lowered the BP by 30 mmHg over several years [6, 7] .
Baroreceptors residing in the aortic arch transduce the arterial pressure curve into a neural signal, which is transferred to the nucleus of the solitary tract in the brainstem via the aortic depressor nerve (ADN). In rats, the ADN is a separate fascicle, typically on the surface of the vagal nerve. Once the ADN is surgically freed from its surrounding tissue and detached from the vagal nerve, bipolar electrical stimulation can activate the baroreflex and lower BP by reducing the sympathetic tone [8] .
As surgical dissection is not an option in human applications, we seek a technique for selectively stimulating the ADN fibers within the vagal nerve bundle by simply wrapping a multichannel cuff electrode (MCE) around the vagus and the accompanying tissue. Once the ADN fibers are detected using a coherent averaging algorithm, we are able to selectively reduce BP without provoking marked bradycardia, which would have been caused by the simple bipolar stimulation of the vagal nerve [9] . In this previous study, we used the static, continuous selective vagal nerve stimulation (sVNS) to immediately reduce BP by up to 60%. As such stimulation might be too energy consuming for the permanent use in a potential neural stimulator, we sought to investigate whether pulsatile, pulse-synchronized sVNS might be an efficient alternative in lowering the BP.
Previous studies have demonstrated that the pulsatile mechanical stimulation of the baroreceptors is more efficient than static pressure in reducing BP [10, 11] . This idea was supported by the observation that the physiologic activity of the ADN is also pulsatile instead of static due to the nature of the pulse wave; i.e., the firing pattern is phasic. Mimicking and overwriting this physiologic signal might potentially be more efficient, as the brainstem expects such pulsatile firing rather than constant high ADN activity. We, therefore, wanted to investigate whether sVNS synchronized with the cardiac-cycle-synchronized (cssVNS) could also reduce BP in a Wistar rat model.
METHODS
The stimulation setup and signal analysis have been previously described [9, 12] .
Surgery
We anesthetized all six male Wistar rats with connected to the data acquisition system and wrapped around the vagal nerve bundle, while the microtip transducer was attached to an in-house-designed amplifier. The amplified BP signal was transferred to the analog input of the data acquisition system. Both the electrocardiogram (ECG) and the transducer signal were digitized with identical parameters using separate input channels of the setup.
MCE
Flexible MCEs were manufactured as previously described [14] . Our MCE exhibited 24 contacts, which were equally pitched in eight tripoles around the cuff perimeter with a 45°spacing [15] . Neurograms were recorded in a true-tripolar manner by the three electrode rings in the center of the cuff cylinder. The two electrodes placed outside of the cuff served as references. The MCE was 10-mm long and had an inner diameter of 0.8 mm. The longitudinal distance between the contacts was 2 mm. The contacts and interconnection lines were manufactured between two layers of polyimide with a total thickness of 11 lm. The 300-nm sputtered platinum thin-film metallization was coated with 1000 nm of sputtered iridium oxide on the contact sites. The ECG was recorded with three subcutaneous needle electrodes on the right and left chest and the left foot.
Identification of Baroreceptor Fibers
We used a PZ3 system (Tucker Davis All experiments were performed in a copper faraday cage connected to a common ground with all other experimental devices. The monopolar recordings were combined with tripolar recordings through two-stage amplification, as described in previous work [9] .
The tripole contacts located near the baroreceptor fibers (ADN) were identified through coherent averaging [16] . These contacts were chosen for the stimulation procedure described below.
Static and Pulsatile sVNS
All stimulation consisted of a given number (one sweep consists of B100 pulses) of current-controlled, charge-balanced biphasic rectangular pulses. The pulses were generated in the PZ3 system (16- Between each sweep, there was a pause (inter-sweep-interval) of at least 10 s. After three sweeps, a pause of 25 s was embedded.
The static stimulation phase was followed by another 5-min recovery phase. The pulsatile stimulation sequence was initiated using the same settings for the stimulation parameters.
For the pulsatile stimulation, each stimulus sweep of 100 pulses had to be collapsed to a series of pulses that would fit the refractory phase of the heartbeat, i.e., the time of blood expulsion. The number of pulses in this time window is a function of the repetition rate of the stimulus. For 30 Hz, we used four pulses; for 40 Hz, we used five pulses; and for 50 Hz, we used seven pulses (see Fig. 2 ). To get as close as possible to the total of 100 pulses per sweep in the static stimulation, we repeated the pulsatile stimulation for 25 heart beats for 30 Hz, for 20 heart beats for 40 Hz, and for 14 heart beats for 50 Hz. Because pulsatile stimulation was triggered by the ECG artifact, the total duration of each stimulation setting depended on the heart rate (HR) during the stimulation (see Fig. 2 ). Each setting of the stimulation parameters was repeated five times. The inter-sweep interval was always 10 s. In the first pulsatile recording, we used every heartbeat to trigger stimulation (P1). After this Fig. 1 Initial readings of all animals. Blood pressure (BP), respiration rate (RR), heart rate (HR), and PQ-time (PQ) of all six test animals (rat 1-6 = R1-R6) after surgery, prior to stimulation. The boxplots represent the median with the upper and lower quartile. All individually pooled vital data were tested for normality. Data sets that failed these tests were labeled not-normal (nn) for non-normal distributed. The blue boxplot in each subplot features the pooled data of all six test animals. All animals showed average BP [in mean arterial pressure (MAP)] between 100 and 120 mmHg. The test animals possessed a RR between 0.8 and 1.2 Hz with test animal one remaining completely beyond 1 Hz. The HR of five animals was in the range of 340-380 beats per minute (BPM). Animal three showed a rather low, but sustained HR in the control measurement resulting in a long extension of the pooled boxplot. The PQ-times of five animals ranged between 45 and 58 ms. PQ of animal two was rather low at 38 ms. If a sample showed a significant difference to any other sample, this was indicated by a star and a linked line. If a sample featured a significant difference to all other samples, the maximum number of stars (highest P-level) was placed above this sample. ns P[0.05; *P B 0.05; **P B 0.01; ***P B 0.001; ****P B 0.0001 stimulation sequence, the test animal was allowed another 5 min to recover. This was followed by a pulsatile stimulation sequence in which we used the same settings, except that we now employed only every second heart beat for stimulation (P2). This was followed by another recovery phase and by a third sequence of pulsatile stimulation, in which we used only every third heart beat for stimulation (P3). Because the interval between the R-peak of the ECG and the increase in the BP pulse wave did not change during the stimulation, this time interval was individually set at the beginning of each pulsatile stimulation sequence using the in-house-written software in Matlab 2015a.
Data Analysis and Statistics
During the initial recording of the vital parameters, all data were pooled and analyzed to determine whether they showed a normal distribution using the D'Agostino-Pearson . Each R-peak of the ECG signal was detected by the software (black arrow indicates the detection). From each R-peak, a given (fixed) delay was obtained (a, light green). In addition, a second interval (b, dark green) was obtained, starting right after the first delay and ending half way prior to the next ECG. Within this green interval, the stimulation pulses of the pulsatile stimulation were placed (indicated by the dotted green vertical lines). The four traces below the red blood pressure (BP) trace illustrate with three examples how the different stimulation settings were arranged (from top to bottom): 30-Hz pulsatile stimulation at every heartbeat (P1), 40 Hz Stimulation at every second heartbeat (P2), 50 Hz stimulation at every third heartbeat (P3) and continuous (static) stimulation. All stimulations consisted of 100 pulses (only 50 Hz was, by calculation, 98 pulses) and were applied over different times: while at 50 Hz, these pulses were applied over a shorter time (2 s), it took 3.3 s during 30 Hz. At the end, the same amount of energy was applied to the nerve, making all results comparable Respiration was not calculated as a rate, because the number of cycles during stimulation was insufficient. However, we used respiration to detect whether apnea occurred during or after the stimulation sweeps in both scenarios (static and pulsatile stimulation).
The BP and HR data for each stimulation sweep of both static and pulsatile stimulation were pooled over all six animals. The pooled data were analyzed for a normal distribution using 
RESULTS

Baseline Vital Parameters
The overall average MAP was 114 mmHg (±9.2 mmHg STD, median = 113 mmHg) (see upper left blue box in Fig. 1 ). The MAP data for all individual test animals as well as the overall pooled data were normally distributed. In a sequential ANOVA test (Holm-Sidak's multiple comparisons), we observed a significant difference only between the BP of rat 1 vs. rat 3 (P = 0.05) (see Fig. 1BP ). The overall average RR was found at 0.94 Hz (±0.1 Hz STD, median = 0.93 Hz). Although the six animals showed a wide range in RRs, all individual and pooled distributions passed the tests for normality. Through parametric multiple comparisons, we found several significant differences between the individual RRs of individual rats. In particular, the RR of rat 5
showed a significant difference against the pooled RR data. Despite the outlier quality of this result, it is still within the range of normal RRs in anesthetized rats and was kept in the pooled distribution.
The average HR was 350 BPM (±45 BPM STD, median = 366 BPM). Because some samples failed the test of normality (HRs marked ''nn'' in Fig. 1 
The average PQ interval occurred at 50 ms (±7 ms STD, median = 51 ms). Again, we observed at least one animal exhibiting a significant deviation from the samples of all other test species. In rat 2, the PQ interval (average = 36 ms, ±1 ms STD) was found to be significantly lower than in all other animals (P\0.01, Dunn's multiple test). Although the data for this sample caused the pooled sample to fail the test of normality, we retained it in the analysis for the same reasons, as in the previous cases.
Across all four vital parameters, we did not find an individual test animal that exhibited significant differences in all four parameters against the pooled sample. In rats 2, 3, and 5, we observed individual ''glitches'' in one of the four vital parameters. The reason for these individual differences was not identified. Similar to the amplitude data, the pulse width results were pooled into three different classes: short (ranging from 0.2 to 0.3 ms), intermediate (ranging from 0.4 to 0.5 ms), and long (ranging from 0.6 to 0.9 ms). In contrast to the findings for the amplitude, the pulse width did not scale up the decrease in BP with an increasing duration. The peak occurred in the mid-range pulse width (27, ±22, 24 mmHg). Shorter (21, ±17, 17 mmHg) and longer (16, ±12, 13 mmHg) pulse widths were less effective.
However, the differences between the three groups did not reach the level of significance. 
BPM). It is noteworthy that an even a reduction of 44
BPMs is equivalent to bradycardia slightly above 10%. However, these differences remained below the level of significance.
As for BP, bradycardia was driven by an increasing stimulation strength. The inter-individual differences in the responses to stimulation were the strongest in this regard.
In pairwise comparisons, only the results from the low-amp stimulation showed a significant difference against the high-amp results (Dunn's multiple test, P\0.05).
The reduction of HR increased slightly with an increasing pulse width. From a short pulse Fig. 4 Analysis of heart rate and blood pressure during selective vagal nerve stimulation. Blood pressure (BP) decrease (first column) and heart rate (HR) decrease (second column) as a function of stimulation frequency (first row), stimulation amplitude (second row), and stimulation duration (third row). The violin plot underneath the boxplots illustrates the distribution function of the data sample, resulting in the boxplot. Gray plots present control (constant stimulation), blue (P1), red (P2), and green (P3) feature pulsatile stimulation at every heartbeat (P1), every second (P2), and every third (P3). All plots feature two scale bars, the left shows the true measure, and the right the normalized measure (in %). In each plot, the control was tested against the pulsatile results for significant differences. Significant differences were marked with an asterisk. While the pulsatile stimulation shows similar capabilities to reduce the BP (at least P1 and P2), the pulsatile stimulation is generally outperforming the constant stimulation in terms of bradycardia. Especially in P2 and P3, the average HR often featured a stimulus-related bradycardia below the threshold of detection (\4%). MAP, mean arterial pressure. ns P[0.05; *P B 0.05; **P B 0.01; ***P B 0.001; ****P B 0.0001 width (33, ±25, 30 BPM) to an intermediate pulse width (34, ±33, 30 BPM), the increase was small, and the high pulse width had a stronger impact (37, ±25, 38 BPM). Again large inter-individual differences became obvious in the violin plot. However, the results for short, intermediate, and long pulse widths did not reach the level of significance using the Dunn's multiple test.
Occurrence of Apnea
The occurrence of apnea across the different stimulation parameters did not follow a linear pathway (see Fig. 5 ). Across all stimulation parameters, the greatest respirational side effects were found at the mid-level. This was the case for the frequency (40 Hz), stimulation amplitude (mid-strength), and pulse width 
All of the pulsatile stimulation conditions resulted in a lower occurrence of apnea with one exception: at a low pulse width, the results of P1 were slightly greater than in the control.
Apnea became a rather rare side effect in P3, and was triggered only under certain combinations of stimulation.
Efficacy Calculation
The BP-reducing effect of pulsatile stimulation is slightly, but not significantly, weaker than that of static stimulation. However, bradycardia is markedly increased during static stimulation.
In Fig. 6 , we emphasized the correlation between the decrease in BP and bradycardia in a normed manner. To determine the efficacy of the stimulation, the decrease in BP in mmHg was divided by the reduction of HR in BPM. 
DISCUSSION
Although medical therapy is the first choice for treating arterial hypertension, up to 50% of patients do not achieve a target BP of below 140 mmHg [1] . Not every patient has therapy-resistant hypertension, and non-compliance can be one of the reasons for this potentially fatal situation [17] , but between 8% and 13% of all hypertensive patients are considered to be truly therapy resistant [18] .
One device-mediated antihypertensive approach is activation of the baroreflex via CSS, which has been investigated since the 1960s by Bilgutay and Neistadt [19] [20] [21] .
Modern CSS has been demonstrated to permanently lower BP by up to 30 mmHg over several years, showing that the concept of antihypertensive baroreflex activation is sound; however, the periprocedural complication rate is high [6, 7] .
Bipolar vagal nerve stimulation has been used to treat therapy-resistant epilepsy since the 1990s, and is associated with a low complication rate [22] . Based on the notion that there are baroreceptor fibers within the vagal nerve from the aortic baroreceptors that are also capable of activating the baroreflex, we recently proposed the technique of antihypertensive sVNS in rats [9] . We found that simultaneously administered Metoprolol or Enalapril only slightly reduces the efficacy of sVNS in rats, without altering its underlying mechanisms [12, 23] .
In our initial study on sVNS, we were able to reduce BP by up to 60% [26] . While these studies indicate that pulsatile BRA is more efficient in reducing BP, it has never been investigated whether pulsatile ADN stimulation synchronized to the cardiac cycle allows a slow, but continuous reduction of BP, without causing relevant side effects.
Our results show that energy-efficient selective pulsatile stimulation of the vagal nerve is nearly free of side effects, can lower the BP and keep it continuously at a desired level.
Limitations of the study: the experiments were performed in six animals. Future studies should include a higher number of animals to consolidate the statistical conclusions. Future studies we plan to perform should also elucidate whether the aspects of this study can be directly transferred to larger animals and humans.
CONCLUSION
CssVNS can continuously reduce BP in male
Wistar rats without altering HR or the PQ interval.
Changing the interval from stimulation at every pulse to every second or third pulse allows BP to be smoothly adjusted to the desired plateau value. CssVNS is, therefore, a promising and energy-efficient technique that might be implemented using antihypertensive selective vagal nerve stimulators in the future.
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